A plethora of data is available regarding the effect of clorgyline, a MAO-A specific inhibitor on mammalian cells due to its effectiveness in the treatment of neurological diseases such as Alzheimer’s and Parkinson’s disease as well as in the treatment of clinical depression. This evidence concerns the gene MAOA and major depressive disorder.